Hypercoagulation Assessed by Thromboelastography is Neither Related to Infarct Size nor to Clinical Outcome After Primary Percutaneous Coronary Intervention

Nadia Paarup Dridi, Jacob T Lønborg, Maria D Radu, Peter Clemmensen, Thomas Engstrøm, Henning Kelbæk, Erik Jørgensen, Steffen Helqvist, Kari Saunamäki, Troels H Christensen, Florian M M Baeres, Pär I Johansson, Lene Holmvang

1 Citation (Scopus)

Abstract

OBJECTIVES: We investigated the relationship between coagulation assessed by thromboelastography (TEG) and myocardial damage in ST-segment elevation myocardial infarction (STEMI).

METHODS: We measured platelet activity with TEG-maximum amplitude (TEG-MA) in 233 patients undergoing urgent percutaneous coronary intervention (PCI). Infarct size and myocardial salvage index were evaluated using cardiac magnetic resonance, and the relation of these parameters to posttreatment coagulation was examined retrospectively. Adverse events were adjudicated and related to the coagulation status during the index event.

RESULTS: Hypercoagulation was found in 82 (35.2%) patients and was neither correlated to infarct size nor correlated to myocardial salvage index (P = .28 and .65, respectively) or clinical adverse events. Patients who experienced an adverse event during follow-up had a slightly higher TEG-MA value than patients with an event-free follow-up, but this was not statistically significant (68.1 vs 67.3, P = .44).

CONCLUSIONS: The TEG-MA does not appear to be a sensitive predictor of reperfusion success and prognosis in urgent PCI for STEMI.

Original languageEnglish
JournalClinical and Applied Thrombosis/Hemostasis
Volume20
Issue number8
Pages (from-to)825-831
Number of pages7
ISSN1076-0296
DOIs
Publication statusPublished - 19 Nov 2014

Fingerprint

Dive into the research topics of 'Hypercoagulation Assessed by Thromboelastography is Neither Related to Infarct Size nor to Clinical Outcome After Primary Percutaneous Coronary Intervention'. Together they form a unique fingerprint.

Cite this